Acadia Healthcare issues 2023 guidance at Investor Day; revenue $2.79B-$2.86B

Acadia Healthcare Company, Inc.

Affirms 2022 guidance: revenue $2.58-2.60B, adj. EBITDA $595-605M, adj. EPS $3.00-3.10.
Provides initial 2023 guidance: revenue $2.79-2.86B, adj. EBITDA $630-680M, adj. EPS $3.10-3.45.
CEO Chris Hunter highlights growth strategy and strong demand; company operates 246 facilities.
Investor Day webcast available; replay accessible for 90 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.